The Department of Justice Antitrust Division has advised several pharmaceutical companies that they can share competitive information regarding the status of their respective efforts to develop a COVID-19 treatment without...more
While this period of crisis due to the pandemic has led competitors to cooperate, the crisis does not serve as an excuse for anticompetitve conduct....more
The Department of Justice Antitrust Division (the “Antitrust Division”) has granted its approval to a plan by a group of medical supply manufacturers to collaborate in response to the COVID-19 pandemic. ...more
Concluding one of the longest merger reviews in history, on September 4, Judge Richard Leon, District Judge for the District of Columbia, issued his final ruling in United States v. CVS Health, approving the proposed...more
9/5/2019
/ Aetna ,
AIDS ,
Antitrust Provisions ,
Competition ,
Corporate Sales Transactions ,
CVS ,
Department of Justice (DOJ) ,
Evidentiary Hearings ,
Final Judgment ,
Health Insurance ,
HIV ,
Medicare Part D ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drug Coverage ,
Public Interest ,
Regulatory Standards ,
Settlement ,
Tunney Act
In a somewhat surprising move, on April 29, 2019 the Florida Legislature passed legislation (HB 21) that repeals the state’s “Certificate of Need” (CON) laws with respect to general hospitals and tertiary services. Such laws,...more
The District of Columbia District Court has again deferred its decision regarding whether to approve the merger between CVS Health and Aetna, a $69 billion transaction that was first announced back in December 2017. ...more
4/11/2019
/ Aetna ,
Antitrust Provisions ,
Competition ,
CVS ,
Department of Justice (DOJ) ,
Health Insurance ,
Joint Venture ,
Medicare Part D ,
Merger Controls ,
Pharmaceutical Industry ,
Pharmacies ,
Popular
The United States Department of Justice Antitrust Division announced on November 15 that it was settling its antitrust lawsuit against Atrium Health (formerly known as Carolinas Health System)....more
The United States Department of Justice Antitrust Division announced on October 10, 2018, that it was conditionally approving the CVS/Aetna merger, a $69 billion transaction that combines the nation’s largest retail pharmacy...more
10/12/2018
/ Aetna ,
Antitrust Division ,
Antitrust Provisions ,
Competition ,
CVS ,
Department of Justice (DOJ) ,
Health Insurance ,
Medicare Part D ,
Pharmacies ,
Popular ,
Regulatory Standards ,
Retailers
On September 17, the United States Department of Justice (DOJ) Antitrust Division issued a “closing statement” in which it announced that it was closing its investigation into Cigna’s proposed acquisition of Express Scripts,...more
In 2012, Marion Healthcare, an outpatient surgery center in southern Illinois, commenced an antitrust action against Southern Illinois Healthcare (“SIH”), a multi-hospital system operating in the same market....more